Lucid Diagnostics Inc. LUCD 深 沪
已收盘 03-27 16:00:00 美东时间
1.12
-0.030
-2.61%
华盛通- 最 高1.165
- 今 开1.15
- 成交量 65.85万股
- 最 低 1.0901
- 昨 收 1.15
- 总市值 1.47亿
- 52周最高 1.80
- 市盈率 静 --
- 换手率 0.50%
- 52周最低 0.9495
- 委 比 46.10%
- 总股本 1.31亿
- 历史最高 13.52
- 量 比 1.29
- 振 幅 6.51%
- 历史最低 0.6301
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Lucid Diagnostics Files Prospectus To Offer And Sell Shares Of Common Stock Of Up To $25M
-SEC Filing
03-27 05:07
Needham Reiterates Buy on Lucid Diagnostics, Maintains $3 Price Target
Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $3 price target.
03-27 00:28
Lucid Diagnostics FY2025 net loss widens to $58 million; revenue rises 8.28% to $4.7 million
Lucid Diagnostics FY2025 net loss widens to $58 million; revenue rises 8.28% to $4.7 million Lucid published a Form 8-K reporting fourth-quarter and full-year 2025 results, including 4Q revenue of USD 1.5 million, up 25.65%. Operating expenses in 4Q were USD 15.5 million, up 14.32%. GAAP net loss at
03-26 20:02
Lucid Diagnostics Q4 Adj. EPS $(0.10), Inline, Sales $1.504M Beat $1.379M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 47.37 percent increase over losses of $(0.19) per share from the same period last year.
03-26 20:01
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Lucid Diagnostics schedules fourth-quarter and full-year 2025 business update call and webcast
Lucid Diagnostics schedules fourth-quarter and full-year 2025 business update call and webcast Lucid Diagnostics will hold a fourth quarter and full year 2025 business update conference call and webcast on March 26, 2026, at 8:30 AM ET. The webcast will be available at luciddx.com . Lishan Aklog wil
03-12 21:10
What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
01-22 22:23
Why Is PAVmed Stock Skyrocketing Wednesday?
Pavmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.
01-22 00:22
PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract
Lucid Diagnostics (LUCD), a subsidiary of healthcare equipment maker PAVmed (PAVM), added ~10% in the premarket on Wednesday after the company announced that the U.S. Department of Veterans Affairs ha...
01-21 21:47
